Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RSMDF) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to $5.0 million.

  • Resmed's Long-Term Debt Repayments changed 0.0% to $5.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.0 million, marking a year-over-year decrease of 9819.82%. This contributed to the annual value of $40.0 million for FY2025, which is 9520.96% down from last year.
  • Latest data reveals that Resmed reported Long-Term Debt Repayments of $5.0 million as of Q4 2025, which was down 0.0% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Resmed's Long-Term Debt Repayments ranged from a high of $300.0 million in Q2 2024 and a low of $5.0 million during Q4 2024
  • Over the past 5 years, Resmed's median Long-Term Debt Repayments value was $103.0 million (recorded in 2021), while the average stood at $103.6 million.
  • As far as peak fluctuations go, Resmed's Long-Term Debt Repayments surged by 76666.67% in 2023, and later tumbled by 9833.33% in 2025.
  • Quarter analysis of 5 years shows Resmed's Long-Term Debt Repayments stood at $136.0 million in 2021, then tumbled by 88.97% to $15.0 million in 2022, then soared by 766.67% to $130.0 million in 2023, then tumbled by 96.15% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q4 2025, $5.0 million for Q2 2025, and $5.0 million during Q4 2024.